Revelation Biosciences Inc (REVB)

2.15 +0.24 (+12.57%)
Closed USD Disclaimer
2.29 +0.14 (+6.51%)

Revelation Biosciences Inc Company Profile

Sector
Healthcare
Employees
6
Equity Type
ORD
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on the active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include REVTx-300, which is being developed as a potential therapy for the prevention and treatment of acute organ injury and chronic organ disease; REVTx-100, which is being developed for the prevention and treatment of infections, including healthcare-associated bacterial infections resulting from surgery, severe burns, and antibiotic resistance; REVTx-200, which is being developed as a potential intranasal therapy that is administered with a traditional commercially available intramuscular (IM) vaccine, and REVTx-99b, which is being developed as a treatment for food allergies.
Contact Information
Address
San Diego,92122 United States
Phone
650 800 3717
Fax
-
Top Executives
Name
Age
Since
Title
George F. Tidmarsh 63 2020 Independent Chairman
James M. Rolke 54 2020 CEO & Director
Jess Roper 58 2020 Independent Director
Julia Bohannon 0 2023 Member of Scientific Advisory Board
Jennifer A. Carver 69 2020 Independent Director
Lakhmir S. Chawla 52 2023 Independent Director
Antonio Hernandez 0 2023 Member of Scientific Advisory Board
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.